NICE nod for Novartis’ Luxturna
The treatment has been approved for RPE65-mediated inherited retinal dystrophies.
Read More
Author: Anna Smith
Greater Manchester NHS declares climate emergency
Organisations are already making progress in reducing carbon emissions and tackling environment degradation.
Read More
Gyroscope Theraputics secures £50.4m Series B financing
Syncona and Cambridge Innovation Capital will contribute £48 million and £2.4 million, respectively.
Read More
NHS warns parents as ‘asthma season’ hits
At this time of year cases can more than double.
Read More
NICE publishes draft cerebral palsy quality standard
The draft standard consists of five statements, which together highlight what needs to be done to ensure adults with cerebral palsy can be “as independent as possible and have equal access to every available opportunity.”
Read More- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
